HER2 Expression May Hold the Key to Predicting Survival Outcomes in CRC
Heinz-Josef Lenz, MD, FACP, discusses the prognostic and predictive value of HER2 expression levels in select patients with colorectal cancer.
Source: onclive.com
Her2 Expression News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Her2 Expression. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Her2 Expression Today - Breaking & Trending Today
Second-Line Therapy for Metastatic TNBC
Shay Elkins, a patient with triple negative breast cancer, shares her experience of relapse six months post-treatment, eventually leading her to seek a second opinion for her recurring symptoms. Dr. Noor Abuhadra discusses second-line treatment options for metastatic triple negative breast cancer, emphasizing newer therapies like antibody drug conjugates and PARP inhibitors, and highlights the evolving landscape that offers hope for patients.
Source: curetoday.com
Tucatinib/Trastuzumab Approval Highlights Expansion of Tailored Therapies in HER2+ CRC
John L. Hays, MD, PhD, discusses the importance of tailoring therapies for patients with CRC who express HER2 or have other actionable targets, the need to develop optimal sequences for local and systemic therapy in CRC, and key updates in hepatocellular carcinoma and pancreatic cancer.
Source: onclive.com